Abstract:Background: Neuroendocrine breast carcinoma (NECB) is a rare, special histologic type of breast cancer. There are some small sample studies on the clinical outcomes of NECB patients, which are worthy of further discussion. Methods: We conducted a retrospective case-control study of clinical characteristics and outcomes among patients with primary NECB versus invasive carcinoma of no special type (NST) between November 2004 and November 2017 in the Peking Union Medical College Hospital, Beijing. NST patients were strictly matched 1:4 during the same period based on the TNM stage. Statistical comparisons were performed to determine the differences in survival between NST and NECB patients and to identify clinical factors that correlate with prognosis. Results: A total of 121 participants affected by primary NECB were included in our analysis from November 2004 to November 2017. Elderly persons (>60 years of age) were more likely to have primary NECB than young persons (p=0.001). In addition, primary NECB patients had significantly higher odds of having tumors 2-5 cm (36.5%) and >5 cm (6.1%) in size than NST patients. Despite a significant difference in tumor size, the proportion of patients with lymph node metastases showed no difference between the two groups (p=0.021). In addition, the rate of patients with ER-negative tumors in the NECB group (4.2%) was significantly lower than that in the primary NST group (29.8%). Significant differences were noted in the PR-negative (13.3% versus 36.6%, P<0.001) and HER2-negative (90.5% versus 76.4%, P=0.001) expression statuses among these patients. Of 121 primary NECB patients, 11 (9.1%) experienced relapses during the follow-up period. We found that tumor size was an independent risk factor for relapse. For hormone receptors on tumor cells, ER-positive breast cancer patients had significantly lower odds of relapse than receptor-negative patients. Conclusions: Our data demonstrate no significant difference in mortality and relapse between the primary NECB and NST groups. The tumor size in the primary NECB group was significantly larger than that in the NST group. In addition, the absence of ER independently increased the relapse rate for breast carcinoma patients.

Neuroendocrine Carcinoma of the Breast: Mammographic Features Correlated with Sonography and Histopathological Findings

Characterization of Single Lesion Nonfunctioning Pancreatic Neuroendocrine Carcinoma Via Computed Tomography

Clinical Analysis of Nasal and Laryngeal Neuroendocrine Carcinoma

Invasive neuroendocrine carcinoma of the breast: a distinctive subtype of aggressive mammary carcinoma

Clinical and Pathologic Analysis of 11 Cases of Primary Breast Neuroendocrine Carcinoma

Molecular cytogenetic characterization of mammary neuroendocrine carcinoma

Neuroendocrine Carcinoma of the Breast is More Aggressive Than Breast Invasive Ductal Carcinoma: A Propensity Score Matching Study Based on SEER Database

Primary Neuroendocrine Tumor of the Breast: Current Understanding and Future Perspectives

Primary Large-Cell Neuroendocrine Carcinoma of the Breast

Imaging Appearance of Primary Hepatic Neuroendocrine Carcinomas

Neuroendocrine Breast Carcinoma: Interesting Images of an Underdiagnosed Entity

Neuroendocrine Carcinomas of the Esophagus: Clinicopathological and Immunohistochemical Features of 43 Cases

Neuroendocrine carcinoma of the endometrium: a retrospective analysis of data from a single center

Comparison of clinical characteristics and outcomes in primary neuroendocrine breast carcinoma versus invasive ductal carcinoma

Small cell neuroendocrine carcinoma of the breast:a clinical and pathological analysis of 3 cases

Neuroendocrine Carcinoma of the Cervix: A Comprehensive Clinicopathologic Study and Literature Review

Small cell neuroendocrine carclinoma of the breast: a clinical and pathological analysis of 3 cases

Neuroendocrine Carcinoma in the Extrahepatic Biliary Tract

Clinicopathological Features of Epstein-Barr Virus-Positive Neuroendocrine Carcinoma: Analysis of Twenty-Two Cases

CT and MRI findings of primary hepatic neuroendocrine carcinoma

Neuroendocrine carcinoma of the common hepatic duct coexisting with distal cholangiocarcinoma: A case report and review of literature